Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $174,000.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 20,000 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $8.70, for a total transaction of $174,000.00. Following the transaction, the insider now owns 1,796,097 shares in the company, valued at approximately $15,626,043.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, July 19th, Dawn Christine Maroney sold 36,700 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.01, for a total transaction of $367,367.00.
• On Wednesday, July 17th, Dawn Christine Maroney sold 23,163 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.00, for a total transaction of $231,630.00.
• On Wednesday, June 12th, Dawn Christine Maroney sold 20,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $8.21, for a total value of $164,200.00.

Alignment Healthcare Trading Up 1.3 %

NASDAQ ALHC opened at $8.70 on Monday. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $10.16. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.57 and a current ratio of 1.57. The company has a market capitalization of $1.66 billion, a price-to-earnings ratio of -10.36 and a beta of 1.43. The company’s 50-day simple moving average is $8.47 and its two-hundred day simple moving average is $6.86.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Thursday, August 1st. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.01. The company had revenue of $681.29 million for the quarter, compared to analyst estimates of $637.66 million. Alignment Healthcare had a negative net margin of 6.85% and a negative return on equity of 95.55%. Alignment Healthcare’s revenue was up 47.3% compared to the same quarter last year. During the same period last year, the company posted ($0.15) earnings per share. Equities analysts forecast that Alignment Healthcare, Inc. will post -0.67 EPS for the current fiscal year.

Institutional Investors Weigh In On Alignment Healthcare

A number of hedge funds have recently made changes to their positions in the stock. Mackenzie Financial Corp grew its stake in Alignment Healthcare by 110.0% in the second quarter. Mackenzie Financial Corp now owns 36,526 shares of the company’s stock valued at $286,000 after purchasing an additional 19,129 shares during the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of Alignment Healthcare by 20.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company’s stock valued at $434,000 after buying an additional 9,595 shares in the last quarter. Deerfield Management Company L.P. Series C grew its position in shares of Alignment Healthcare by 31.8% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after buying an additional 2,630,788 shares during the last quarter. AQR Capital Management LLC bought a new position in shares of Alignment Healthcare during the 2nd quarter worth approximately $1,512,000. Finally, Hood River Capital Management LLC lifted its position in Alignment Healthcare by 6.4% during the second quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company’s stock valued at $24,294,000 after acquiring an additional 185,854 shares during the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ALHC has been the subject of a number of research analyst reports. Barclays raised their price target on Alignment Healthcare from $4.50 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, August 5th. TD Cowen lifted their target price on Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a research report on Tuesday, August 6th. Stifel Nicolaus upped their price target on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a report on Friday, July 26th. Stephens lifted their price objective on shares of Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a report on Friday, May 3rd. Finally, Piper Sandler reissued an “overweight” rating and issued a $10.00 price objective (up from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $10.05.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.